Close

Drug Research

Thermo Fisher Launches Adolescent Alopecia Areata Registry

Thermo Fisher Scientific Inc., the global leader in serving science, has announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry. This initiative addresses a significant unmet need for real-world, adolescent-specific data on alopecia areata, an autoimmune...

FDA Approves Roche’s Susvimo for Diabetic Macular Edema

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL as the first and only continuous delivery treatment for diabetic macular edema (DME), a leading cause of vision loss in adults...

Refeyn introduces new mass photometry products to streamline biomolecular analysis workflows

Refeyn, the company behind pioneering mass photometry technologies, has taken another step to assure mass photometry is a simpler, more efficient bioanalytics tool with the release of a powerful expansion of its consumables portfolio. The introduction of next-generation microfluidic...

RoukenBio completes phase 2 discovery centre expansion and unveils new brand identity

RoukenBio, the Collaborative Research Organisation (CRO) formerly known as Antibody Analytics, has today announced completion of the phase 2 expansion of its Discovery Centre in Motherwell, Scotland. In addition to this key business milestone, the immunology CRO has unveiled its...

Revolutionizing Drug Valuation With Real-World Evidence

Determining the value of a medicine may be a challenging task. To put it another way, how much is the value of a patient's life? Adding real-world data to the standard equation in order to provide a more focused...

Role of AI In Transforming Drug Discovery And Development

Artificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production. By leveraging AI technologies, pharmaceutical companies can streamline processes, reduce costs, and enhance the accuracy and speed of drug...

AI-Driven Route Scouting Revolutionizes Drug Development

Lonza is revolutionizing drug development with its AI-driven route scouting technology, allowing pharmaceutical companies to fast-track their investigational new drug (IND) submissions. By integrating artificial intelligence (AI) into their processes, Lonza has been able to significantly reduce the time...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read